385 related articles for article (PubMed ID: 21190793)
1. Long-term follow-up of bladder cancer patients with disseminated tumour cells in bone marrow.
Retz M; Rotering J; Nawroth R; Buchner A; Stöckle M; Gschwend JE; Lehmann J
Eur Urol; 2011 Aug; 60(2):231-8. PubMed ID: 21190793
[TBL] [Abstract][Full Text] [Related]
2. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.
Ribal MJ; Mengual L; Marín M; Algaba F; Ars E; Fernández PL; Oliva R; Villavicencio H; Alcaraz A
Anticancer Res; 2006; 26(1A):411-9. PubMed ID: 16475726
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
Efstathiou JA; Spiegel DY; Shipley WU; Heney NM; Kaufman DS; Niemierko A; Coen JJ; Skowronski RY; Paly JJ; McGovern FJ; Zietman AL
Eur Urol; 2012 Apr; 61(4):705-11. PubMed ID: 22101114
[TBL] [Abstract][Full Text] [Related]
4. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients.
Hautmann RE; de Petriconi RC; Pfeiffer C; Volkmer BG
Eur Urol; 2012 May; 61(5):1039-47. PubMed ID: 22381169
[TBL] [Abstract][Full Text] [Related]
5. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
7. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.
Rosenblatt R; Sherif A; Rintala E; Wahlqvist R; Ullén A; Nilsson S; Malmström PU;
Eur Urol; 2012 Jun; 61(6):1229-38. PubMed ID: 22189383
[TBL] [Abstract][Full Text] [Related]
8. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
[TBL] [Abstract][Full Text] [Related]
9. Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy.
May M; Herrmann E; Bolenz C; Tiemann A; Brookman-May S; Fritsche HM; Burger M; Buchner A; Gratzke C; Wülfing C; Trojan L; Ellinger J; Tilki D; Gilfrich C; Höfner T; Roigas J; Zacharias M; Gunia S; Wieland WF; Hohenfellner M; Michel MS; Haferkamp A; Müller SC; Stief CG; Bastian PJ
Eur Urol; 2011 May; 59(5):712-8. PubMed ID: 21296488
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.
Rink M; Chun FK; Dahlem R; Soave A; Minner S; Hansen J; Stoupiec M; Coith C; Kluth LA; Ahyai SA; Friedrich MG; Shariat SF; Fisch M; Pantel K; Riethdorf S
Eur Urol; 2012 Apr; 61(4):810-7. PubMed ID: 22277196
[TBL] [Abstract][Full Text] [Related]
11. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
[TBL] [Abstract][Full Text] [Related]
12. External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patients.
van Onna IE; Oddens JR; Kok ET; van Moorselaar RJ; Bosch JL; Battermann JJ
Eur Urol; 2009 Jul; 56(1):113-21. PubMed ID: 18722048
[TBL] [Abstract][Full Text] [Related]
13. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
Solsona E; Climent MA; Iborra I; Collado A; Rubio J; Ricós JV; Casanova J; Calatrava A; Monrós JL
Eur Urol; 2009 Apr; 55(4):911-9. PubMed ID: 18722046
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement?
Gazquez C; Ribal MJ; Marín-Aguilera M; Kayed H; Fernández PL; Mengual L; Alcaraz A
BJU Int; 2012 Nov; 110(9):1310-6. PubMed ID: 22416928
[TBL] [Abstract][Full Text] [Related]
15. Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma.
Rioja J; Bandrés E; Rosell Costa D; Rincón A; López I; Zudaire Bergera JJ; García Foncillas J; Gil MJ; Panizo A; Plaza L; Rioja LA; Berián Polo JM
BJU Int; 2011 Jun; 107(11):1833-8. PubMed ID: 20840328
[TBL] [Abstract][Full Text] [Related]
16. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis.
Illert B; Fein M; Otto C; Cording F; Stehle D; Thiede A; Timmermann W
Scand J Gastroenterol; 2005 Jul; 40(7):843-9. PubMed ID: 16109661
[TBL] [Abstract][Full Text] [Related]
17. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma.
Copp HL; Chin JL; Conaway M; Theodorescu D
Cancer; 2006 Jul; 107(1):60-6. PubMed ID: 16691580
[TBL] [Abstract][Full Text] [Related]
19. Comparative outcomes of primary, recurrent, and progressive high-risk non-muscle-invasive bladder cancer.
Thomas F; Noon AP; Rubin N; Goepel JR; Catto JW
Eur Urol; 2013 Jan; 63(1):145-54. PubMed ID: 22985746
[TBL] [Abstract][Full Text] [Related]
20. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
